Simulations Plus (NASDAQ:SLP) CRO John Anthony Dibella II Sells 1,000 Shares

Simulations Plus, Inc. (NASDAQ:SLP) CRO John Anthony Dibella II sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, July 6th. The stock was sold at an average price of $18.36, for a total value of $18,360.00. Following the completion of the sale, the executive directly owned 86,140 shares of the company’s stock, valued at approximately $1,581,530.40. This represents a 1.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John Anthony Dibella II also recently made the following trade(s):

• On Wednesday, April 15th, John Anthony Dibella II sold 1,000 shares of Simulations Plus stock. The stock was sold at an average price of $13.37, for a total transaction of $13,370.00.

Simulations Plus Stock Down 0.1%

Shares of NASDAQ:SLP opened at $18.27 on Thursday. The stock has a market cap of $369.05 million, a PE ratio of -5.84 and a beta of 1.30. The company’s fifty day moving average is $16.40 and its 200 day moving average is $15.48. Simulations Plus, Inc. has a 52 week low of $11.09 and a 52 week high of $21.01.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.08. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%.The company had revenue of $24.29 million during the quarter, compared to analyst estimates of $21.66 million. Sell-side analysts anticipate that Simulations Plus, Inc. will post 0.8 EPS for the current year.

Institutional Trading of Simulations Plus

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Royal Bank of Canada raised its stake in Simulations Plus by 26.6% during the 1st quarter. Royal Bank of Canada now owns 114,885 shares of the technology company’s stock valued at $2,817,000 after purchasing an additional 24,132 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after acquiring an additional 390 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in Simulations Plus during the 1st quarter valued at $255,000. Woodline Partners LP raised its stake in shares of Simulations Plus by 32.1% in the first quarter. Woodline Partners LP now owns 13,239 shares of the technology company’s stock valued at $325,000 after acquiring an additional 3,220 shares during the period. Finally, Rhumbline Advisers raised its position in Simulations Plus by 12.2% in the 2nd quarter. Rhumbline Advisers now owns 74,325 shares of the technology company’s stock worth $1,297,000 after purchasing an additional 8,103 shares during the period. 78.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SLP has been the subject of a number of recent analyst reports. Weiss Ratings upgraded Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, June 5th. Craig Hallum lowered shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price for the company. in a report on Thursday, June 18th. Wall Street Zen cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. William Blair downgraded Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th. Finally, TD Cowen dropped their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 10th. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Simulations Plus has a consensus rating of “Hold” and an average target price of $19.88.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.